| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919534 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Moderate to severe faecal incontinence is common amongst anal cancer survivors. Post-treatment follow-up should include the evaluation of continence, and incontinent survivors should be offered better symptom management and multidisciplinary approach if simple measures are insufficient.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anne Gry Bentzen, Marianne G. Guren, Barthold Vonen, Eva H. Wanderås, Gunilla Frykholm, Tom Wilsgaard, Olav Dahl, Lise Balteskard,